Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Brad Bissell

Emergency Medicine Monroe, NC Medical Doctor

NPI 1205026903 CMS profile 824407

1423 E Franklin St, Ste B, Monroe, NC 28112

Open in the dashboard

General payments

$1,906

110 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brad Bissell of Monroe, NC is reported in the CMS Open Payments database as having received $1,906 across 110 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $705 40
2024 General $601 35
2023 General $307 23
2022 General $156 8
2021 General $117 2
2020 General $20 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brad Bissell
  • Emergency Medicine median
  • Middle half of Emergency Medicine
  • National median

In program year 2025, general payments to Brad Bissell were reported at $705. Among 10,690 Emergency Medicine profiles paid that year, the median was $57 and the middle half received between $24 and $150.

Show as a table
Year Brad Bissell Emergency Medicine median Middle half National median
2019 $0 $51 $18–$128 $163
2020 $20 $29 $16–$99 $114
2021 $117 $40 $18–$124 $132
2022 $156 $49 $20–$134 $149
2023 $307 $51 $22–$142 $160
2024 $601 $52 $22–$150 $164
2025 $705 $57 $24–$150 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Smith+Nephew, Inc. $932 70 payments
  2. Organogenesis Inc. $354 12 payments
  3. Kerecis Limited $128 3 payments
  4. Next Science LLC $120 7 payments
  5. Solventum Corporation $75 3 payments
  6. Cashflow Solutions, LLC $69 4 payments
  7. BSN Medical Inc $40 1 payment
  8. Molnlycke Health Care US, LLC $25 1 payment
  9. ConvaTec Inc. $24 1 payment
  10. Coloplast Corp $24 1 payment
  11. Other $115 7 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $1,906 110 payments
Products named General payments · program years 2020–2025
  1. GRAFIX PL Other Advanced Wound Management $381 25 payments
  2. GRAFIX PL Other Advanced Wound Management $270 23 payments
  3. Affinity $140 3 payments
  4. Puraply $116 6 payments
  5. Kerecis Omega3 SurgiClose $104 1 payment
  6. Kerecis Omega3 Wound $104 1 payment
  7. Kerecis Omega3 Surgibind $104 1 payment
  8. Kerecis Omega3 GraftGuide $104 1 payment
  9. Xperience $100 6 payments
  10. BlastX $100 6 payments
  11. Other $1,274 76 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

224

Median for Emergency Medicine: 88

Drug cost

$44,414

Median for Emergency Medicine: $590

Branded share of claims

46.4%

Median for Emergency Medicine: 33.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Tobramycin Sulfate Generic 24 $42,407
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 44 $477
Doxycycline Hyclate Generic 23 $355
Ciprofloxacin Hcl Generic 22 $296
Nystatin Generic 12 $193
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 41 $192
Gabapentin Generic 22 $179
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 19 $164
Triamcinolone Acetonide Generic 17 $150

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 40,243 Part D prescribers listed as Emergency Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 24 billing codes

Paid by Medicare

$86,690

Medicare's payments for the services billed

Medicare patients

208

Average age 75

Services billed

1,875

99 women, 109 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 50%
Arthritis 50%
Atrial fibrillation 40%
Chronic kidney disease 40%
Ischemic heart disease 37%
Heart failure 32%
Depression 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

110 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Emergency Medicine in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record